| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |